Low-dose vaginal estrogen products are considered distinct from systemic estrogen therapies, with systemic therapies delivering hormone throughout the body via formulations such as oral pills and transdermal patches.
high
definitional
Clinical distinction used when evaluating localized versus systemic menopausal estrogen treatments.